# Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation

> **NCT00755781** · PHASE3 · COMPLETED · sponsor: **APT Pharmaceuticals, Inc.** · enrollment: 284 (actual)

## Conditions studied

- Lung Transplant

## Interventions

- **DRUG:** Cyclosporine Inhalation Solution (CIS)

## Key facts

- **NCT ID:** NCT00755781
- **Lead sponsor:** APT Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-11
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2012-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755781, "Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00755781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*